387 Intractable Crohn's disease is a common cause of chronic intestinal failure among adult patients. Intestinal transplantation has recently evolved to be the only life saving therapy for patients who cannot be maintained on TPN. Materials and Methods: Crohn's disease was the cause of irreversible intestinal failure in 11 (23%) out of 48 adult patients who received intestinal transplantation at our institution during the period from May 1990 to December 1998. Six patients were male and 5 were female with a mean age of 38 ± 10 years. Two of the 11 patients received combined liver-intestine because of hepatointestinal failure and the remaining 9 received isolated intestine. The indications for isolated intestinal transplantation were vanishing central venous access (n=4), frequent line sepsis (n=8), persistent fluid and electrolyte disturbances (n=5), and impending liver failure (n=2). All recipients had multiple abdominal surgery with a median of 10 operations (range: 2-19) and received TPN therapy for a median of 80 months (range: 15-156). All donors were cadaveric and primary immunosuppression was with tacrolimus and steroids. Results: The median operative time of transplantation was 11.9 hours (range: 15-22.5). Defective abdominal wall with contracture of the abdominal cavity that required major plastic reconstruction was observed in 3 patients. With a mean follow-up of 26 months (range:0.4-82), 5 (45%) patients (4 isolated intestine, 1 liver-intestine) are currently alive with fully functioning grafts. The causes of patient/graft loss were respiratory failure (n=3), rejection (n=1), technical (n=1), and narcotic overdose (n=1). None of the grafts have developed recurrent disease. The incidence, frequency, and severity of rejection were similar to that of a well matched historical control group. Cytomegaloviral disease developed in 5 (45%) of the patients and was intractable in 3. None of the recipients had PTLD or graft versus host disease. Conclusions: 1) Intestinal transplantation is a life saving therapy for Crohn's disease patients with intestinal failure who can no longer be maintained on TPN. 2) Crohn's disease does not increase the risk of intestinal allograft rejection. 3) The potential risk of disease recurrence has yet to be demonstrated in our series.
Read full abstract